EDP-323 is an investigational inhibitor of Respiratory Syncytial Virus (RSV), currently showing promising results in Phase 2a ...

Gilead Sciences, Inc. (Nasdaq: GILD) and Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today ...

A mom of three young children, Craig resident Tanisha Young, 29, recently lost her dad, and in past times in her life, that ...

Vir Biotechnology, Inc. (NASDAQ:VIR) today announced it will present new data from the Phase 2 SOLSTICE clinical trial ...

Alchemy, which sets up pharmacies in community clinics, said that it had raised $31 million from Andreessen Horowitz and ...

SIGNIFICANT milestone in the health sector has been achieved as Kairuki Hospital introduces High-Intensity Focused Ultrasound ...

According to the CDC, 25 million new cases are reported ... gonorrhea, hepatitis, HIV, and syphilis at some point in your pregnancy, so you can get treatment and take precautions during delivery.

Kezar Life Sciences said on Thursday it would terminate its mid-stage trial studying its experimental drug in patients with active lupus nephritis and focus on the development of the drug in ...

Residents of New Town's Shrachi Greenwood Nest highrise report outbreaks of typhoid and hepatitis A due to poor water quality ...

Dehradun: In a tragic incident, a final-year medical student of Haldwani Medical College succumbed to a heart attack on ...

With the aim of increasing access to precision care, GE HealthCare is proud to collaborate with University Medicine Essen ...